OEZVY yields 4.13% · JNJ yields 2.13%● Live data
📍 OEZVY pulled ahead of the other in Year 1
Combined, OEZVY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OEZVY + JNJ for your $10,000?
VERBUND AG, together with its subsidiaries, generates, trades, and sells electricity to energy exchanges, traders, electric utilities and industrial companies, and households and commercial customers in Austria and internationally. It operates through Hydro, New Renewables, Sales, Grid, and All Other segments. As of December 31, 2021, the company operated hydropower plants with a capacity of 8,307 megawatts (MW); wind farms with a capacity of 418 MW; solar farms with a capacity of 3 MW; and thermal power plants with an electrical capacity of 1,013 MW. It also operates electricity transmission network in Austria, as well as long-distance gas pipeline and gas distribution network; trades and sells gas; and provides energy-related services. The company was formerly known as Österreichische Elektrizitätswirtschafts- Aktiengesellschaft and changed its name to VERBUND AG in 2010. VERBUND AG was founded in 1947 and is headquartered in Vienna, Austria.
Full OEZVY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.